首页 > 最新文献

Journal of Pharmaceutical and Scientific Innovation最新文献

英文 中文
FORMULATION AND EVALUATION OF MEFENAMIC ACID MICROSPHERES BY IONIC GELATION TECHNIQUE 离子凝胶法制备甲氧胺酸微球及评价
Pub Date : 2022-10-26 DOI: 10.7897/2277-4572.115236
Subhashitha S, Ashitha Meharooz, Haseena ., Nasheel Shereen, Ravi Kumar
The aim of the present investigation is to prepare mefenamic acid microspheres by ionic gelation technique. A total of three formulations were prepared by altering the polymer ratio. The obtained microspheres were evaluated for drug entrapment efficiency, swelling index, and in vitro drug release. Out of three formulation F3 formulation i.e., (1:2) drug: polymer ratio was found to best formulation with high product yield, Drug entrapment efficiency, Swelling index, and in vitro drug release.
本研究的目的是利用离子凝胶技术制备甲胺酸微球。通过改变聚合物的比例,共制备了三种配方。对制备的微球进行药物包封效率、溶胀指数和体外药物释放度评价。在3种制剂中,F3制剂即(1:2)药聚合物比为最佳制剂,产率高、包封效率高、溶胀指数高、体外释药效果好。
{"title":"FORMULATION AND EVALUATION OF MEFENAMIC ACID MICROSPHERES BY IONIC GELATION TECHNIQUE","authors":"Subhashitha S, Ashitha Meharooz, Haseena ., Nasheel Shereen, Ravi Kumar","doi":"10.7897/2277-4572.115236","DOIUrl":"https://doi.org/10.7897/2277-4572.115236","url":null,"abstract":"The aim of the present investigation is to prepare mefenamic acid microspheres by ionic gelation technique. A total of three formulations were prepared by altering the polymer ratio. The obtained microspheres were evaluated for drug entrapment efficiency, swelling index, and in vitro drug release. Out of three formulation F3 formulation i.e., (1:2) drug: polymer ratio was found to best formulation with high product yield, Drug entrapment efficiency, Swelling index, and in vitro drug release.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81251780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VALIDATION OF SCREENING MODELS OF EPILEPSY: A REVIEW 癫痫筛查模型的验证:综述
Pub Date : 2022-08-30 DOI: 10.7897/2277-4572.114235
Ankita Tripathi, Shubham Srivastava, K. Bhardwaj, Sristi Raj, N. .
Epilepsy is a severe neurological illness characterized by abnormal, recurring, and synchronized brain discharges. Long-term recurring seizure attacks can cause substantial brain function loss, as seen in people with temporal lobe epilepsy. Controlling seizure events is critical for epilepsy therapy and prognosis. The disease is more common in developing countries than in developed countries. The causes of epilepsy include chemical imbalances such as low blood sugar or sodium, head injuries, drug abuse or withdrawal, alcohol withdrawal, stroke tumor affecting the blood vessels (vascular system) in the brain, hardening of the arteries (atherosclerosis) in the brain, brain tumours, and brain infections such as meningitis or encephalitis. Given the prevalence of epilepsy and the challenges associated with currently available antiepileptic medicines, such as side effects, resistance, safety concerns, and high cost, screening models are utilized in epilepsy analysis. Screening models for seizures and epilepsy have been critical in expanding our understanding of the fundamental mechanisms underlying ictogenesis and epileptogenesis, as well as in the discovery and preclinical development of novel antiepileptic medicines (AEDs). Diverse screening models of epilepsy have been developed in recent years to imitate various seizure forms, with no clear advantages or disadvantages. In this study, we will cover the numerous screening models for epilepsy, which will aid in gaining a better understanding of the disease.
癫痫是一种严重的神经系统疾病,其特征是异常的、反复出现的和同步的脑放电。长期反复发作的癫痫发作会导致严重的脑功能丧失,就像颞叶癫痫患者一样。控制癫痫发作事件对癫痫治疗和预后至关重要。这种疾病在发展中国家比在发达国家更为常见。癫痫的病因包括化学失衡,如低血糖或钠、头部受伤、药物滥用或戒断、戒酒、影响大脑血管(血管系统)的中风肿瘤、大脑动脉硬化(动脉粥样硬化)、脑肿瘤和脑感染,如脑膜炎或脑炎。鉴于癫痫的流行以及与现有抗癫痫药物相关的挑战,如副作用、耐药性、安全性问题和高成本,筛查模型被用于癫痫分析。癫痫发作和癫痫的筛查模型对于扩大我们对icogenesis和epilepsy发生的基本机制的理解,以及对新型抗癫痫药物(aed)的发现和临床前开发至关重要。近年来开发了多种癫痫筛查模型来模拟各种发作形式,但没有明显的优缺点。在这项研究中,我们将涵盖众多的癫痫筛查模型,这将有助于更好地了解这种疾病。
{"title":"VALIDATION OF SCREENING MODELS OF EPILEPSY: A REVIEW","authors":"Ankita Tripathi, Shubham Srivastava, K. Bhardwaj, Sristi Raj, N. .","doi":"10.7897/2277-4572.114235","DOIUrl":"https://doi.org/10.7897/2277-4572.114235","url":null,"abstract":"Epilepsy is a severe neurological illness characterized by abnormal, recurring, and synchronized brain discharges. Long-term recurring seizure attacks can cause substantial brain function loss, as seen in people with temporal lobe epilepsy. Controlling seizure events is critical for epilepsy therapy and prognosis. The disease is more common in developing countries than in developed countries. The causes of epilepsy include chemical imbalances such as low blood sugar or sodium, head injuries, drug abuse or withdrawal, alcohol withdrawal, stroke tumor affecting the blood vessels (vascular system) in the brain, hardening of the arteries (atherosclerosis) in the brain, brain tumours, and brain infections such as meningitis or encephalitis. Given the prevalence of epilepsy and the challenges associated with currently available antiepileptic medicines, such as side effects, resistance, safety concerns, and high cost, screening models are utilized in epilepsy analysis. Screening models for seizures and epilepsy have been critical in expanding our understanding of the fundamental mechanisms underlying ictogenesis and epileptogenesis, as well as in the discovery and preclinical development of novel antiepileptic medicines (AEDs). Diverse screening models of epilepsy have been developed in recent years to imitate various seizure forms, with no clear advantages or disadvantages. In this study, we will cover the numerous screening models for epilepsy, which will aid in gaining a better understanding of the disease.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"70 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88147854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FORMULATION AND EVALUATION OF FOOT CREAM FROM FICUS RACEMOSA 总状榕足霜的配方及评价
Pub Date : 2022-08-30 DOI: 10.7897/2277-4572.114233
V. Bhat, Nisha Ullas Naik, Kushal R, Sinchana A Shetty, V. Shetty, Surekha Devadiga, R. Nayak
Feet are our body’s substructure, so keeping them healthy is indispensable to our overall health. From ancient time variety of herbs have been used to treat different foot diseases. In this study, the main aim is the preparation of foot cream using Ficus racemosa (cluster fig) plant extract. Its biological active ingredients, such as Gluconal acetate, β-sitosterol, lupeol and lupeol acetate produces wound healing, antioxidant, anti-inflammatory, and anti-fungal activity over skin surface. The main objective of this research work includes the complete qualification of wound healing or screening, and it is useful to obtain good foot cream for topical application. Preparation of foot cream using Ficus racemosa was done and its evaluation was carried out on various parameters. The used product is compatible with other ingredients present in the formulation.
脚是我们身体的底层结构,所以保持脚的健康对我们的整体健康是必不可少的。自古以来,各种草药被用来治疗不同的足病。本研究的主要目的是利用总状榕植物提取物制备足霜。其生物活性成分,如醋酸葡糖醇、β-谷甾醇、鹿皮醇和醋酸鹿皮醇,在皮肤表面具有伤口愈合、抗氧化、抗炎和抗真菌活性。本研究工作的主要目的包括伤口愈合或筛选的完整资格,并有助于获得良好的足霜局部应用。以总状榕为原料制备足霜,并对其各项参数进行了评价。使用的产品与配方中存在的其他成分相容。
{"title":"FORMULATION AND EVALUATION OF FOOT CREAM FROM FICUS RACEMOSA","authors":"V. Bhat, Nisha Ullas Naik, Kushal R, Sinchana A Shetty, V. Shetty, Surekha Devadiga, R. Nayak","doi":"10.7897/2277-4572.114233","DOIUrl":"https://doi.org/10.7897/2277-4572.114233","url":null,"abstract":"Feet are our body’s substructure, so keeping them healthy is indispensable to our overall health. From ancient time variety of herbs have been used to treat different foot diseases. In this study, the main aim is the preparation of foot cream using Ficus racemosa (cluster fig) plant extract. Its biological active ingredients, such as Gluconal acetate, β-sitosterol, lupeol and lupeol acetate produces wound healing, antioxidant, anti-inflammatory, and anti-fungal activity over skin surface. The main objective of this research work includes the complete qualification of wound healing or screening, and it is useful to obtain good foot cream for topical application. Preparation of foot cream using Ficus racemosa was done and its evaluation was carried out on various parameters. The used product is compatible with other ingredients present in the formulation.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90906343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VALIDATION OF SCREENING MODEL FOR MENINGITIS: A REVIEW 脑膜炎筛查模型的验证:综述
Pub Date : 2022-08-30 DOI: 10.7897/2277-4572.114234
Ankita Tripathi, Utsav Gupta, Pooja Chaurasiya, Priya Pandey, Sristi Raj
Meningitis is a condition caused by the inflammation of the meninges. Meningitis can be caused by bacteria, viruses, fungi, parasites, and amebic. Interestingly some meningitis is infectious, while other is non-infectious. The non-infectious causes of meningitis are autoimmune illnesses, cancer/paraneoplastic syndromes, and medication responses. There are several risk factors associated with meningitis, like a defect in the dural, alcoholism, age, medical condition, some kind of exposure, and so on. Since meningitis is a serious and delicate condition, the need of several screening models is required to validate meningitis. These models depend on thematical calculations like regression models, multiple regression models, and logistic models, and some animal models are also there for meningitis. Hence, here we discussed meningitis and models briefly.
脑膜炎是一种由脑膜炎症引起的疾病。脑膜炎可由细菌、病毒、真菌、寄生虫和阿米巴原虫引起。有趣的是,有些脑膜炎是传染性的,而另一些则是非传染性的。脑膜炎的非感染性原因是自身免疫性疾病、癌症/副肿瘤综合征和药物反应。有几个与脑膜炎相关的危险因素,如硬脑膜缺陷、酗酒、年龄、医疗状况、某种暴露等等。由于脑膜炎是一种严重而微妙的疾病,需要几种筛查模型来验证脑膜炎。这些模型依赖于回归模型、多元回归模型和逻辑模型等主题计算,还有一些脑膜炎的动物模型。因此,在这里我们简要地讨论脑膜炎和模型。
{"title":"VALIDATION OF SCREENING MODEL FOR MENINGITIS: A REVIEW","authors":"Ankita Tripathi, Utsav Gupta, Pooja Chaurasiya, Priya Pandey, Sristi Raj","doi":"10.7897/2277-4572.114234","DOIUrl":"https://doi.org/10.7897/2277-4572.114234","url":null,"abstract":"Meningitis is a condition caused by the inflammation of the meninges. Meningitis can be caused by bacteria, viruses, fungi, parasites, and amebic. Interestingly some meningitis is infectious, while other is non-infectious. The non-infectious causes of meningitis are autoimmune illnesses, cancer/paraneoplastic syndromes, and medication responses. There are several risk factors associated with meningitis, like a defect in the dural, alcoholism, age, medical condition, some kind of exposure, and so on. Since meningitis is a serious and delicate condition, the need of several screening models is required to validate meningitis. These models depend on thematical calculations like regression models, multiple regression models, and logistic models, and some animal models are also there for meningitis. Hence, here we discussed meningitis and models briefly.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"2000 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88303990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PREPARATION AND STANDARDIZATION OF CHITRAKADI VATI 腊肠的制备及标准化
Pub Date : 2022-06-30 DOI: 10.7897/2277-4572.113230
Shilpa Patel, Nikunj Patadiya, Pooja Makvana, Rikin Patel
The present work deals with the preparation and standardization of chitrakadi vati. All the parameters of both market formulation (MF1 & MF2) and Laboratory formulation (LF) were found to be within the limit prescribed in pharmacopoeia. Average weight and weigh variation of LF was 2057 mg and 0.2±0.1 %, disintegration time was 8±2 min, hardness was 4.6±0.2 Kg/cm2 , friability was 0.9722±0.2 %, ash values were 2.4 % (acid insoluble ash) and 2.15 % (water soluble ash), extractive values were 5.6 % (acid insoluble extractive) and 7.25 % (water soluble extractive). In order to ensure quality and stability of final product, some of the important chemical markers has been separated from the mixture and for analysis by high performance thin layer chromatography was selected for qualitative and quantitative purpose. The results of standardization parameters showed marked difference among three, which fingers to authenticity of market formulations. Even HPTLC fingerprinting showed some ingredients in market formulations were taken adulterated or inferior in quality. The HPTLC method for fingerprinting was found to be precise and accurate to quantify three chemical markers plumbagin (0.84%), piperine (0.92%), zingiberene (0.71%), and it further characterized by IR, NMR, Mass spectra.
本文主要研究了腊肠的制备和标准化。市场剂型(MF1和MF2)和实验室剂型(LF)的各项参数均在药典规定范围内。其平均重量和重量变化分别为2057 mg和0.2±0.1%,崩解时间为8±2 min,硬度为4.6±0.2 Kg/cm2,脆度为0.9722±0.2%,灰分值分别为2.4%(酸不溶性灰分)和2.15%(水溶性灰分),提取率分别为5.6%(酸不溶性灰分)和7.25%(水溶性灰分)。为了保证最终产品的质量和稳定性,从混合物中分离出一些重要的化学标记物,并选择高效薄层色谱进行定性和定量分析。标准化参数的结果在三者之间存在显著差异,这与市场配方的真实性有关。甚至HPTLC指纹图谱也显示出市场配方中存在掺假或质量低劣的成分。hplc指纹图谱测定方法准确、准确地定量了水杨桃苷(0.84%)、胡椒碱(0.92%)、姜黄烯(0.71%)3种化学标记物,并通过IR、NMR、质谱对其进行了表征。
{"title":"PREPARATION AND STANDARDIZATION OF CHITRAKADI VATI","authors":"Shilpa Patel, Nikunj Patadiya, Pooja Makvana, Rikin Patel","doi":"10.7897/2277-4572.113230","DOIUrl":"https://doi.org/10.7897/2277-4572.113230","url":null,"abstract":"The present work deals with the preparation and standardization of chitrakadi vati. All the parameters of both market formulation (MF1 & MF2) and Laboratory formulation (LF) were found to be within the limit prescribed in pharmacopoeia. Average weight and weigh variation of LF was 2057 mg and 0.2±0.1 %, disintegration time was 8±2 min, hardness was 4.6±0.2 Kg/cm2 , friability was 0.9722±0.2 %, ash values were 2.4 % (acid insoluble ash) and 2.15 % (water soluble ash), extractive values were 5.6 % (acid insoluble extractive) and 7.25 % (water soluble extractive). In order to ensure quality and stability of final product, some of the important chemical markers has been separated from the mixture and for analysis by high performance thin layer chromatography was selected for qualitative and quantitative purpose. The results of standardization parameters showed marked difference among three, which fingers to authenticity of market formulations. Even HPTLC fingerprinting showed some ingredients in market formulations were taken adulterated or inferior in quality. The HPTLC method for fingerprinting was found to be precise and accurate to quantify three chemical markers plumbagin (0.84%), piperine (0.92%), zingiberene (0.71%), and it further characterized by IR, NMR, Mass spectra.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91515366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A CASE REPORT ON KATIGAT VATA WITH SPECIAL REFERENCE TO LUMBAR SPONDYLOSIS 腰椎病伴腰椎病1例报告
Pub Date : 2022-06-30 DOI: 10.7897/2277-4572.113231
Sadhana Nalawade, D. Padavi
According to Ayurveda Katigat vata is one of the types of Vata vyadhi explained in our ancient Ayurvedic text. It arises due to Prakop of Aata dosha and Asthi dhatu kshaya. Similarly Lumbar Spondylosis is a degenerative disorder affecting the discs and the vertebral bodies of the lumbar spine. Patients with lumbar spondylosis have pain in their axial spine which affects most of the people in the later stage of their lives. A 75 years old female having a history of katigat vata for the last 6 years so she approached Dr. DY Patil Ayurvedic Hospital for Ayurvedic management. Patient was having a progressive pain in her lower back with restricted movements. She was treated for 75 days including Panchakarma therapies. The response to the treatment was recorded and therapeutic effects were evaluated with a reduction of clinical symptoms of the patient. This case study evaluates that Ayurvedic management, in this case, was very effective treating Katigata vata successfully without any side effects.
根据阿育吠陀,Katigat vata是我们古老的阿育吠陀文本中解释的vata vyadhi的一种类型。它是由于Aata dosha和Asthi dhatu kshaya的Prakop而产生的。同样,腰椎病是一种影响腰椎椎间盘和椎体的退行性疾病。腰椎病患者的中轴脊柱疼痛,这影响了大多数人的晚年生活。一名75岁的女性,过去6年一直有妊娠史,因此她来到帕蒂尔阿育吠陀医院寻求阿育吠陀治疗。患者腰背部进行性疼痛,活动受限。她接受了75天的治疗,包括Panchakarma疗法。记录对治疗的反应,并通过患者临床症状的减轻来评估治疗效果。本案例研究评估了阿育吠陀治疗,在这种情况下,是非常有效的治疗Katigata vata成功,没有任何副作用。
{"title":"A CASE REPORT ON KATIGAT VATA WITH SPECIAL REFERENCE TO LUMBAR SPONDYLOSIS","authors":"Sadhana Nalawade, D. Padavi","doi":"10.7897/2277-4572.113231","DOIUrl":"https://doi.org/10.7897/2277-4572.113231","url":null,"abstract":"According to Ayurveda Katigat vata is one of the types of Vata vyadhi explained in our ancient Ayurvedic text. It arises due to Prakop of Aata dosha and Asthi dhatu kshaya. Similarly Lumbar Spondylosis is a degenerative disorder affecting the discs and the vertebral bodies of the lumbar spine. Patients with lumbar spondylosis have pain in their axial spine which affects most of the people in the later stage of their lives. A 75 years old female having a history of katigat vata for the last 6 years so she approached Dr. DY Patil Ayurvedic Hospital for Ayurvedic management. Patient was having a progressive pain in her lower back with restricted movements. She was treated for 75 days including Panchakarma therapies. The response to the treatment was recorded and therapeutic effects were evaluated with a reduction of clinical symptoms of the patient. This case study evaluates that Ayurvedic management, in this case, was very effective treating Katigata vata successfully without any side effects.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89586194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL STUDY ON EFFECT OF VAMANA AND UDVARTANA KARMA IN THE MANAGEMENT OF STHOULYA 心业与心业在脑瘫治疗中的临床研究
Pub Date : 2022-02-27 DOI: 10.7897/2277-4572.111225
J. ., Sidram Guled
Introduction: The incidence of Obesity is increasing day by day in more percentage due to sedentary lifestyle and food habits and is resulting into many serious systemic complications. Sthoulya is kapha pradhana and medo-pradoshaja vyadhi. Charaka samhita mentioned Sthoulya disease under the eight varieties of personalities which are designated as Astha Nindita Purusha. Sthoulya is kapha and meda predominant vyadhi and vamana karma is prime therapy and it eliminates kapha and meda. Udvartana is another important therapy in Sthoulya that results in kapha meda vilayana and hence the present study is entitled as “Clinical study on effect of Vamana and Udvartana karma in the management of Sthoulya” was planned. Aims and Objectives: To evaluate the efficacy of the Vamana karma, Udvartana in Sthoulya and to compare and assess the effect of both the therapies. Materials And Methods: Total 30 patients were selected, distributed in 2 equal groups, Group A treated with Vamana karma and Group B treated with Udvartana. Observations And Results: The progress was assessed based on subjective parameters considered by giving scores to the clinical signs and symptoms and objective parameters were done before treatment and after treatment with a specially prepared case proforma. Discussion and Conclusion: All the patients in both groups were responded positively without any complications. Group A with Vamana showed highly significant results in symptoms; Atikshudha, Ati pipasa, Nidradhikya, Shrama and Hyperlipidemia. Group B with Udvartana also showed highly significant results in symptoms like Nidradhikya, Swedadhikya, Dourgandya, Shrama and Alasya.
由于久坐不动的生活方式和饮食习惯,肥胖的发病率日益增加,并导致许多严重的全身并发症。Sthoulya是kapha pradhana和media -pradoshaja vyadhi。《查罗伽》在八种人格中提到了soulya病,这些人格被指定为Astha Nindita Purusha。Sthoulya是kapha和媒质的主导,vyadhi和vamana业力是主要的治疗,它消除了kapha和媒质。Udvartana是Sthoulya中的另一种重要疗法,可导致kapha meda vilayana,因此本研究的标题为“Vamana和Udvartana业力在Sthoulya管理中的作用的临床研究”。目的和目的:评估在Sthoulya的Vamana业力,Udvartana的功效,并比较和评估两种疗法的效果。材料与方法:选择30例患者,随机分为两组,A组用Vamana karma治疗,B组用Udvartana治疗。观察与结果:以临床体征和症状评分为主观参数,以治疗前和治疗后特制的病例形式进行客观参数评估。讨论与结论:两组患者均反应良好,无并发症发生。服用Vamana的A组在症状方面表现出非常显著的效果;Atikshudha, Ati pipasa, Nidradhikya, Shrama和高脂血症。患有Udvartana的B组在Nidradhikya、Swedadhikya、Dourgandya、Shrama和Alasya等症状中也显示出非常显著的结果。
{"title":"CLINICAL STUDY ON EFFECT OF VAMANA AND UDVARTANA KARMA IN THE MANAGEMENT OF STHOULYA","authors":"J. ., Sidram Guled","doi":"10.7897/2277-4572.111225","DOIUrl":"https://doi.org/10.7897/2277-4572.111225","url":null,"abstract":"Introduction: The incidence of Obesity is increasing day by day in more percentage due to sedentary lifestyle and food habits and is resulting into many serious systemic complications. Sthoulya is kapha pradhana and medo-pradoshaja vyadhi. Charaka samhita mentioned Sthoulya disease under the eight varieties of personalities which are designated as Astha Nindita Purusha. Sthoulya is kapha and meda predominant vyadhi and vamana karma is prime therapy and it eliminates kapha and meda. Udvartana is another important therapy in Sthoulya that results in kapha meda vilayana and hence the present study is entitled as “Clinical study on effect of Vamana and Udvartana karma in the management of Sthoulya” was planned. Aims and Objectives: To evaluate the efficacy of the Vamana karma, Udvartana in Sthoulya and to compare and assess the effect of both the therapies. Materials And Methods: Total 30 patients were selected, distributed in 2 equal groups, Group A treated with Vamana karma and Group B treated with Udvartana. Observations And Results: The progress was assessed based on subjective parameters considered by giving scores to the clinical signs and symptoms and objective parameters were done before treatment and after treatment with a specially prepared case proforma. Discussion and Conclusion: All the patients in both groups were responded positively without any complications. Group A with Vamana showed highly significant results in symptoms; Atikshudha, Ati pipasa, Nidradhikya, Shrama and Hyperlipidemia. Group B with Udvartana also showed highly significant results in symptoms like Nidradhikya, Swedadhikya, Dourgandya, Shrama and Alasya.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"398 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82167001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EVALUATION OF IN VITRO ANTIUROLITHIATIC ACTIVITY OF ETHANOLIC EXTRACT OF PAVONIA ZEYLANICA (L) CAV 白芍乙醇提取物体外抗尿石活性评价
Pub Date : 2022-02-27 DOI: 10.7897/2277-4572.111226
V. J, N. P
Objective: To evaluate in vitro antiurolithiatic activities of Pavonia zeylanica (L) Cav. Material and Methods: Whole plant of Ethanolic extract of Pavonia zeylanica was prepared and arranged in the three different concentrations (10mg/ml, 20mg/ml, and 30mg/ml). In vitro antiurolithiatic activity of Ethanolic extract of Pavonia zeylanica through turbidometric and titrimetric method was tested in terms of inhibition of calcium oxalate by nucleation and aggregation and dissolution of calcium oxalate, using the standard drug. Results: Standard drug has high percentage inhibition and dissolution ability and thus Ethanolic extract of Pavonia zeylanica also have a good percentage inhibition and dissolution ability was comparable to standard drug. Conclusion: The study concludes that the Ethanolic extract of Pavonia zeylanica have inhibitory effect on calcium oxalate for nucleation and aggregation assay. It also showed good dissolution of calcium oxalate crystals, so this extract has the good protection against Urolithiasis activity
目的:评价白花巴冬的体外抗尿石活性。材料与方法:制备全株白花Pavonia zelanica乙醇提取物,并以10mg/ml、20mg/ml、30mg/ml三种不同浓度排列。采用浊度法和滴定法,以草酸钙成核聚集和溶解度为标准药物,考察了白花苜蓿醇提物体外抗尿石活性。结果:标准药具有较高的百分比抑制度和溶出度,因此白花巴冬醇提物也具有与标准药相当的百分比抑制度和溶出度。结论:芡实醇提物对草酸钙成核聚集试验具有抑制作用。草酸钙晶体溶解性好,具有良好的抗尿石活性
{"title":"EVALUATION OF IN VITRO ANTIUROLITHIATIC ACTIVITY OF ETHANOLIC EXTRACT OF PAVONIA ZEYLANICA (L) CAV","authors":"V. J, N. P","doi":"10.7897/2277-4572.111226","DOIUrl":"https://doi.org/10.7897/2277-4572.111226","url":null,"abstract":"Objective: To evaluate in vitro antiurolithiatic activities of Pavonia zeylanica (L) Cav. Material and Methods: Whole plant of Ethanolic extract of Pavonia zeylanica was prepared and arranged in the three different concentrations (10mg/ml, 20mg/ml, and 30mg/ml). In vitro antiurolithiatic activity of Ethanolic extract of Pavonia zeylanica through turbidometric and titrimetric method was tested in terms of inhibition of calcium oxalate by nucleation and aggregation and dissolution of calcium oxalate, using the standard drug. Results: Standard drug has high percentage inhibition and dissolution ability and thus Ethanolic extract of Pavonia zeylanica also have a good percentage inhibition and dissolution ability was comparable to standard drug. Conclusion: The study concludes that the Ethanolic extract of Pavonia zeylanica have inhibitory effect on calcium oxalate for nucleation and aggregation assay. It also showed good dissolution of calcium oxalate crystals, so this extract has the good protection against Urolithiasis activity","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"149 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78035643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A PRAGMATIC CLINICAL APPROACH ON EFFECTIVENESS AND MANAGEMENT OF JANUMARMABHIGHATA 一种实用的临床方法探讨野麻泻的疗效和管理
Pub Date : 2021-12-30 DOI: 10.7897/2277-4572.106219
R. ., Chandini Sg, A. R., A. S, A. S
Ayurveda is one of the field which carries a huge acceleration in revitalisation. The rejuvenation of local health tradition had been continued after independence, though in a slow speed. The practice of Marma Chikitsa is more prevalent in Kerala and South Tamil Nadu and plays a key role even today. The importance of Ayurveda is even accepted by Western scholars in this high-tech era is worth to note. According to day-to-day clinical practise, Ayurvedic treatment shows better results in mild, moderate and severe cases of Janumarmabhighata. Hence, this study was undertaken to find out effective treatment for the Vikaras caused by Janumarmabhighata. 30 patients were selected for the current study according to derived inclusion and exclusion criteria, from OPD and IPD of Government Ayurveda college hospital, Trivandrum, Kerala. The case history of each patient was recorded as per the proforma designed. 10 patients were each tabulated under three groups containing janumarmabhighata lakshana like A, B, C groups (mild/moderate/severe) respectively, after assessing subjective and objective symptoms. Similarly, treatment protocol also was framed out in three different categories according to general line of management for sandhimarma kshata and janumarmabhighata. Remarkable improvement was noticed in each category after treatment. Assessment of clinical recovery in terms of pain, tenderness, swelling, wasting, muscle strength, flexion and extension in 3 groups were statistically also significant.
阿育吠陀是其中一个领域,承载着巨大的加速振兴。独立后,地方卫生传统的复兴一直在继续,但速度缓慢。Marma Chikitsa的做法在喀拉拉邦和南泰米尔纳德邦更为普遍,即使在今天也发挥着关键作用。值得注意的是,在这个高科技时代,阿育吠陀的重要性甚至被西方学者所接受。根据日常临床实践,阿育吠陀疗法对轻、中、重度Janumarmabhighata均有较好的疗效。因此,本研究旨在寻找由Janumarmabhighata引起的Vikaras的有效治疗方法。根据导出的纳入和排除标准,从喀拉拉邦特里凡得琅政府阿育吠陀学院医院的OPD和IPD中选择了30例患者进行本研究。根据所设计的表格记录每位患者的病史。将10例患者分别分为A、B、C组(轻/中/重度),评估主观和客观症状。同样地,治疗方案也根据三害性发作和二害性发作的一般管理方法分为三种不同的类别。治疗后各指标均有显著改善。3组患者在疼痛、压痛、肿胀、消瘦、肌力、屈伸等方面的临床恢复评估也有统计学意义。
{"title":"A PRAGMATIC CLINICAL APPROACH ON EFFECTIVENESS AND MANAGEMENT OF JANUMARMABHIGHATA","authors":"R. ., Chandini Sg, A. R., A. S, A. S","doi":"10.7897/2277-4572.106219","DOIUrl":"https://doi.org/10.7897/2277-4572.106219","url":null,"abstract":"Ayurveda is one of the field which carries a huge acceleration in revitalisation. The rejuvenation of local health tradition had been continued after independence, though in a slow speed. The practice of Marma Chikitsa is more prevalent in Kerala and South Tamil Nadu and plays a key role even today. The importance of Ayurveda is even accepted by Western scholars in this high-tech era is worth to note. According to day-to-day clinical practise, Ayurvedic treatment shows better results in mild, moderate and severe cases of Janumarmabhighata. Hence, this study was undertaken to find out effective treatment for the Vikaras caused by Janumarmabhighata. 30 patients were selected for the current study according to derived inclusion and exclusion criteria, from OPD and IPD of Government Ayurveda college hospital, Trivandrum, Kerala. The case history of each patient was recorded as per the proforma designed. 10 patients were each tabulated under three groups containing janumarmabhighata lakshana like A, B, C groups (mild/moderate/severe) respectively, after assessing subjective and objective symptoms. Similarly, treatment protocol also was framed out in three different categories according to general line of management for sandhimarma kshata and janumarmabhighata. Remarkable improvement was noticed in each category after treatment. Assessment of clinical recovery in terms of pain, tenderness, swelling, wasting, muscle strength, flexion and extension in 3 groups were statistically also significant.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85808028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ATURA PARIJNANA HETU VIS-A-VIS HEALTH GEOGRAPHY: A REVIEW
Pub Date : 2021-12-30 DOI: 10.7897/2277-4572.106221
Arpita H R, Anand Katti
Health is a state of equilibrium of doshas, dhatu, mala, atma and indriya. In deceased condition it is necessary to maintain the balance between the doshas and bringing back to their normalcy. Ayurveda had described various tools for diagnosing various diseases one among that is roga and rogi pariksha. Roga pariksha is done by assessing nidana panchakas while rogi pariksha is done by dwividha, trividha, chaturvida, ashtavida, dashavidha pariksha.In the context of desha pariksha Acharya Charaka has mentioned bhumi pariksha and In Atura pariksha he has mentioned atura parijnana hetu which explains in detail about relationship between the desha and atura from the birth how these factors contribute a role in developing a disease, which helps in diagnosing the condition of the patient, health geography deals with the interaction between people and environment, It conceptualize the role of place, location and geography in health ,well-being and disease.
健康是doshas、dhatu、mala、atma和indriya的平衡状态。在死亡的情况下,有必要保持dosha之间的平衡,并使其恢复正常。阿育吠陀描述了诊断各种疾病的各种工具,其中之一是roga和rogi pariksha。Roga parikha是通过评估内观(nidana panchakas)来完成的,而rogi parikha是通过评估外观(wiwiha)、外观(triviha)、外观(chaturvida)、实观(ashtavia)、大观(dashavidha parikha)来完成的。在desha pariksha的背景下,Acharya Charaka提到了bhumi pariksha在Atura pariksha中,他提到了Atura parijnana hetu详细解释了从出生开始desha和Atura之间的关系这些因素如何在疾病的发展中发挥作用,这有助于诊断病人的状况,健康地理学研究人与环境之间的相互作用,它将地点的作用概念化,健康、幸福和疾病的地理位置。
{"title":"ATURA PARIJNANA HETU VIS-A-VIS HEALTH GEOGRAPHY: A REVIEW","authors":"Arpita H R, Anand Katti","doi":"10.7897/2277-4572.106221","DOIUrl":"https://doi.org/10.7897/2277-4572.106221","url":null,"abstract":"Health is a state of equilibrium of doshas, dhatu, mala, atma and indriya. In deceased condition it is necessary to maintain the balance between the doshas and bringing back to their normalcy. Ayurveda had described various tools for diagnosing various diseases one among that is roga and rogi pariksha. Roga pariksha is done by assessing nidana panchakas while rogi pariksha is done by dwividha, trividha, chaturvida, ashtavida, dashavidha pariksha.In the context of desha pariksha Acharya Charaka has mentioned bhumi pariksha and In Atura pariksha he has mentioned atura parijnana hetu which explains in detail about relationship between the desha and atura from the birth how these factors contribute a role in developing a disease, which helps in diagnosing the condition of the patient, health geography deals with the interaction between people and environment, It conceptualize the role of place, location and geography in health ,well-being and disease.","PeriodicalId":16738,"journal":{"name":"Journal of Pharmaceutical and Scientific Innovation","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75190346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pharmaceutical and Scientific Innovation
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1